Dr. Liron Bar-Peled of the Massachusetts General Hospital Cancer Center is recipient of funding from the the Evan Schumacher Fund for Rare Cancer Research at TargetCancer Foundation. In this video, Dr. Bar-Peled discusses his work identifying his creative strategies for identifying new targets for treatment in cholangiocarcinoma and other difficult to treat cancers.
